FOLH1 and prostate carcinoma: PSMA-617 can be labeled with positron-emitters (e.g., 68Ga) for imaging or with radionuclides suitable for therapy (e.g., 177Lu, 225Ac) of recurrent prostate carcinoma [2,3].